Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius SE & Co (FSNUY)
OTHER OTC:FSNUY
Holding FSNUY?
Track your performance easily
FSNUY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.62 - $9.66
Previous CloseN/A
Volume6.04K
Average Volume (3M)70.00K
Market Cap
$21.50B
Enterprise Value$35.36B
Total Cash (Recent Filing)$1.83B
Total Debt (Recent Filing)$12.84B
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Mar 26, 2025EPS Estimate
0.19Last Dividend Ex-Date
May 18, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding2,252,949,200
10 Day Avg. Volume54,865
30 Day Avg. Volume69,998
Standard Deviation0.10
R-Squared0.28
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.52
Price to Cash Flow (P/CF)2.90
P/FCF Ratio5.10
Enterprise Value/Market Cap1.64
Enterprise Value/Revenue0.87
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda5.46
Forecast
1Y Price Target
$11.50Price Target Upside18.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Fresenius SE & Co News
PremiumCompany Announcements
Fresenius SE: Confirms Growth Amid Strategic Adjustments
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
FSNUY FAQ
What was Fresenius SE & Co’s price range in the past 12 months?
Fresenius SE & Co lowest stock price was $6.62 and its highest was $9.66 in the past 12 months.
What is Fresenius SE & Co’s market cap?
Fresenius SE & Co’s market cap is $21.50B.
When is Fresenius SE & Co’s upcoming earnings report date?
Fresenius SE & Co’s upcoming earnings report date is Mar 26, 2025 which is in 54 days.
How were Fresenius SE & Co’s earnings last quarter?
Fresenius SE & Co released its earnings results on Nov 06, 2024. The company reported $0.185 earnings per share for the quarter, beating the consensus estimate of $0.177 by $0.008.
Is Fresenius SE & Co overvalued?
According to Wall Street analysts Fresenius SE & Co’s price is currently Undervalued.
Does Fresenius SE & Co pay dividends?
Fresenius SE & Co pays a Annually dividend of $0.167 which represents an annual dividend yield of N/A. See more information on Fresenius SE & Co dividends here
What is Fresenius SE & Co’s EPS estimate?
Fresenius SE & Co’s EPS estimate is 0.19.
How many shares outstanding does Fresenius SE & Co have?
Fresenius SE & Co has 2,252,949,200 shares outstanding.
What happened to Fresenius SE & Co’s price movement after its last earnings report?
Fresenius SE & Co reported an EPS of $0.185 in its last earnings report, beating expectations of $0.177. Following the earnings report the stock price went up 1.085%.
Which hedge fund is a major shareholder of Fresenius SE & Co?
Currently, no hedge funds are holding shares in FSNUY
---
Fresenius SE & Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.50 (18.80% Upside)
$11.50 (18.80% Upside)
Blogger Sentiment
Bullish
FSNUY Sentiment 100%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.35%
12-Months-Change
Fundamentals
Return on Equity
3.14%
Trailing 12-Months
Asset Growth
-40.71%
Trailing 12-Months
Company Description
Fresenius SE & Co
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises dialysis products and healthcare services. The Fresenius Kabi segment specializes intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.
---
FSNUY Company Deck
---
FSNUY Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Fresenius demonstrated strong financial performance and growth across key segments, particularly Kabi and Helios. However, challenges remain with the continued softness in China and the end of energy relief funding impacting Helios. The company's upgraded guidance reflects confidence in its performance, but interest expenses pose a future risk.Read More>---
FSNUY Stock 12 Month Forecast
Average Price Target
$11.50
▲(18.80% Upside)
Technical Analysis
Best Analysts Covering FSNUY
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+20.40%
reiterated a buy rating 9 months ago
Copying James Vane's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.40% per trade.
---